OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma…
Mt. Olive, NJ, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (Nasdaq: VISL) (“Vislink” or the “Company”), a global…
NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Nvni Group Limited (Nasdaq: NVNI) (“Nuvini”) today announced that it has received…
NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Nvni Group Limited (Nasdaq: NVNI) (“Nuvini”) today announced that it has received…
November 15, 2024 17:00 ET | Source: Eagle Pharmaceuticals, Inc. WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Eagle…
ATLANTA, GA, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company,” “we” or “our”) (NYSE American: RHE)…
